Please login to the form below

Not currently logged in

ClinTec appoints regional manager for Spain and Portugal

Carlos Palacios joins the contract research organisation

Contract research organisation ClinTec International has appointed Carlos Palacios to the newly-created position of regional manager for Spain and Portugal.

The appointment comes as the UK-headquartered clinical service provider expands its Spanish business, moving to a larger office in Barcelona and opening a new location in Madrid.

Palacios joins ClinTec from Merck, where he served as its clinical account manager and site relationship and operations lead, overseeing global trials across Spain, Portugal, Israel and the Netherlands.

He brings over 16 years of experience in the clinical research industry at local and global levels to the organisation, having previously held management roles at Chiltern International, drug Solutions and Merck & Co.

Dr Rabinder Buttar, founder and chief executive officer of ClinTec, said: “The creation of the new regional management post and the opening of the two new offices in Madrid and Barcelona signal that ClinTec is developing and expanding in line with our current client's needs and that as a company we are ready to take on new business of all sizes.

“I am delighted Carlos has joined our team at ClinTec as we continue to expand our business in the Spanish and Portuguese region.”

31st May 2016

From: Sales



Featured jobs

Subscribe to our email news alerts


Add my company
Six Degrees Medical Consulting

Partnering with top global pharmaceutical companies, we push the boundaries to create meaningful, impactful and lasting learning opportunities. We leverage...

Latest intelligence

Waking the sleeping giant
The lights are coming on for healthcare delivery in Africa...
How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...